Lipase is an enzyme, which helps in the hydrolysis of fats and reduces the formation of glycerol and fatty acids in all living beings. It plays a vital role in the process of digestion by transporting and processing the ester bonds in triglycerides. In addition, it helps in the keeping of pancreatic enzymes to an optimum level. Health disorders such as bloating, indigestion and abdominal discomfort are caused by the consumption of high carbohydrate and fatty food items. Lipases help in the prevention of diabetes, cholesterol, obesity and high triglycerides. Lipases are generally produced with the help of microbial sources such as fungi, yeast and bacteria. Bacteria and fungi lipases are preferred the most in the enzymes industry. Microbial lipases can be more effective than lipases that are obtained from animals and plants because of its variety in high yield, ease of genetic modification and catalytic activities.
Lipase is one of the largest growing markets in the enzymes market due to its health and industrial advantages. In food and non food industries, lipases are used as shelf life enhancers, flavorants, texturants and cleaning agents. Lipases also find huge application in animal feeds, where it is used in improving the health of livestock. In addition, lipases are used for medical and diagnostic use. Blood test with the help of lipase can help detect acute pancreatitis and other disorders in the pancreas of human body. Lipases also assist patients undergoing pancreatic enzyme replacement therapy (PERT), where it helps in the breakdown of fats into lipids.
Rise in the consumption of processed dairy products and meat and increasing awareness of animal health are the major driving factors of the global lipase market. In addition, multiple health benefits associated with the use of lipase in human bodies is also set to bolster the global lipase market. The restraint inhibiting the global lipase market is the lack of transparency in the law of patent protection across the globe.
Request PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7942
The global lipase market has been segmented by source, which includes animal lipases and microbial lipases. In addition, the market has been categorized by application, which includes animal feed, dairy, bakery, confectionary and others. By geography, it has been segmented into North America, Europe, Asia Pacific, Latin America and Rest of the World (RoW).
In the global lipase market, Asia Pacific witnessed the largest revenue in 2014, and by the end of the forecast period from 2015 to 2023, Asia Pacific is expected to show significant growth. Countries in the Asia Pacific such as India, China and Japan are the considered to be the largest growing markets in the region. The Asia Pacific lipase market is followed by North America, Europe, Latin America and Rest of the World (RoW).
Some of the key players in the global lipase market include Amano Enzymes Inc., Novozymes A/S, Chr. Hansen Holdings A/S, E. I. du Pont Nemours and Company, Koninklijke DSM N.V., Renco New Zealand, Clerici-Sacco Group, Associated British Foods Plc and Advanced Enzymes among others.
This post was originally published on Denton Chronicle